Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 1
2006 7
2007 4
2008 2
2009 5
2010 4
2011 10
2012 10
2013 5
2014 10
2015 10
2016 12
2017 14
2018 22
2019 11
2020 18
2021 21
2022 28
2023 25
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines.
Groheux D, Vaz SC, Ulaner GA, Cook GJR, Woll JPP, Mann RM, Poortmans P, Cardoso F, Jacene H, Graff SL, Rubio IT, Peeters MV, Dibble EH, de Geus-Oei LF. Groheux D, et al. Among authors: de geus oei lf. Eur J Nucl Med Mol Imaging. 2024 May 2. doi: 10.1007/s00259-024-06694-x. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38693453 No abstract available.
Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
Collarino A, Feudo V, Pasciuto T, Florit A, Pfaehler E, de Summa M, Bizzarri N, Annunziata S, Zannoni GF, de Geus-Oei LF, Ferrandina G, Gambacorta MA, Scambia G, Boellaard R, Sala E, Rufini V, van Velden FH. Collarino A, et al. Among authors: de geus oei lf. J Nucl Med. 2024 Mar 28:jnumed.123.267044. doi: 10.2967/jnumed.123.267044. Online ahead of print. J Nucl Med. 2024. PMID: 38548352
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).
Hendriks P, Rietbergen DDD, van Erkel AR, Coenraad MJ, Arntz MJ, Bennink RJ, Braat AE, Crobach S, van Delden OM, Dibbets-Schneider P, van der Hulle T, Klümpen HJ, van der Meer RW, Nijsen JFW, van Rijswijk CSP, Roosen J, Ruijter BN, Smit F, Stam MK, Takkenberg RB, Tushuizen ME, van Velden FHP, de Geus-Oei LF, Burgmans MC; Dutch Hepatocellular and Cholangiocarcinoma Group. Hendriks P, et al. Among authors: de geus oei lf. Eur J Nucl Med Mol Imaging. 2024 Feb 8. doi: 10.1007/s00259-024-06630-z. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38329507
Impact of the COVID-19 pandemic on the in-hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population-based study.
Wolfkamp W, Meijer J, van Hoeve JC, van Erning F, de Geus-Oei LF, de Hingh I, Veltman J, Siesling S; COVID and Cancer-NL Consortium. Wolfkamp W, et al. Among authors: de geus oei lf. Cancer Med. 2024 Jan 10;13(1):e6861. doi: 10.1002/cam4.6861. Online ahead of print. Cancer Med. 2024. PMID: 38197670 Free PMC article.
How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.
Ambrosini V, Carrilho Vaz S, Ahmadi Bidakhvidi N, Chanchou M, Cysouw MCF, Serani F, Voltin CA, Kraeber-Bodere F, Deroose CM, De Geus-Oei LF, Eiber M, Gnanasegaran G, Gotthardt M, Kobe C, Konijnenberg MW, Nanni C, Oprea Lager DE, Rahbar K, Taieb D, Mottaghy FM, Goffin K, Herrmann K. Ambrosini V, et al. Among authors: de geus oei lf. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):3-11. doi: 10.1007/s00259-023-06389-9. Eur J Nucl Med Mol Imaging. 2023. PMID: 37689611 Free PMC article. No abstract available.
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Pasquier D, Bidaut L, Oprea-Lager DE, deSouza NM, Krug D, Collette L, Kunz W, Belkacemi Y, Bau MG, Caramella C, De Geus-Oei LF, De Caluwé A, Deroose C, Gheysens O, Herrmann K, Kindts I, Kontos M, Kümmel S, Linderholm B, Lopci E, Meattini I, Smeets A, Kaidar-Person O, Poortmans P, Tsoutsou P, Hajjaji N, Russell N, Senkus E, Talbot JN, Umutlu L, Vandecaveye V, Verhoeff JJC, van Oordt WMH, Zacho HD, Cardoso F, Fournier L, Van Duijnhoven F, Lecouvet FE. Pasquier D, et al. Among authors: de geus oei lf. Lancet Oncol. 2023 Aug;24(8):e331-e343. doi: 10.1016/S1470-2045(23)00286-3. Lancet Oncol. 2023. PMID: 37541279 Review.
Intraprocedural assessment of ablation margins using computed tomography co-registration in hepatocellular carcinoma treatment with percutaneous ablation: IAMCOMPLETE study.
Hendriks P, van Dijk KM, Boekestijn B, Broersen A, van Duijn-de Vreugd JJ, Coenraad MJ, Tushuizen ME, van Erkel AR, van der Meer RW, van Rijswijk CS, Dijkstra J, de Geus-Oei LF, Burgmans MC. Hendriks P, et al. Among authors: de geus oei lf. Diagn Interv Imaging. 2024 Feb;105(2):57-64. doi: 10.1016/j.diii.2023.07.002. Epub 2023 Jul 28. Diagn Interv Imaging. 2024. PMID: 37517969 Free article.
199 results